INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 294 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,221 | +8.3% | 80,752 | +20.1% | 0.02% | +30.8% |
| Q4 2023 | $2,051 | +106.3% | 67,252 | +113.9% | 0.01% | +44.4% |
| Q3 2023 | $994 | +235.8% | 31,436 | +333.1% | 0.01% | +350.0% |
| Q2 2023 | $296 | -14.9% | 7,258 | -27.3% | 0.00% | -60.0% |
| Q4 2022 | $348 | -100.0% | 9,982 | -41.9% | 0.01% | -61.5% |
| Q3 2022 | $962,000 | +135.2% | 17,186 | +117.5% | 0.01% | +160.0% |
| Q2 2022 | $409,000 | -67.4% | 7,903 | -54.2% | 0.01% | -68.8% |
| Q1 2022 | $1,253,000 | +169.5% | 17,243 | +397.3% | 0.02% | +166.7% |
| Q3 2021 | $465,000 | -6.4% | 3,467 | -62.0% | 0.01% | +20.0% |
| Q4 2020 | $497,000 | -54.3% | 9,134 | -83.3% | 0.01% | -77.3% |
| Q3 2020 | $1,088,000 | +33.2% | 54,723 | +40.7% | 0.02% | +4.8% |
| Q2 2020 | $817,000 | +366.9% | 38,882 | +197.1% | 0.02% | +250.0% |
| Q3 2019 | $175,000 | – | 13,089 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |